Athenex, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about news in Athenex, Inc..

The service is free and you can unsubscribe at any time.

General | People (48) | Filings (69) | Investment rounds (10) | Stock | News

Industry: PHARMACEUTICAL PREPARATIONS [2834]

CIK Number: 0001300699
IRS Number: 431985966

Athenex, Inc. is a publicly traded company

Trading symbol: ATNX

Athenex, Inc. is on the market more than 5 years.

News

2017-08-14

Athenex, Inc. Announces Second Quarter 2017 Results
Nasdaq
BUFFALO, N.Y., Aug. 14, 2017 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer, today announced its ...
ATHENEX INC (ATNX) Releases Quarterly Earnings Results - Week Herald

2017-08-10

Athenex Pharma Solutions, an Athenex, Inc. Company, Launches Three New Sterile ...
Nasdaq
BUFFALO, N.Y., Aug. 10, 2017 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer, today announced the ...

2017-08-01

Athenex Announces Recent Product Launches in Commercial Business
GlobeNewswire (press release)
BUFFALO, N.Y., Aug. 01, 2017 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer, today announced ...

2017-07-31

Athenex, Inc. to Report Second Quarter 2017 Earnings Results on August 14, 2017
Nasdaq
BUFFALO, N.Y., July 31, 2017 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer, today announced that it ...

2017-07-27

Athenex, Inc. Announces Approval of Tax Incentives from State of New York for ...
Nasdaq
BUFFALO, N.Y., July 27, 2017 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer, today announced that it ...

2017-07-25

IDA Grants Tax Incentives For Athenex Construction
Jamestown Post Journal
Bair was accompanied by Richard Nasser, Athenex official who will oversee the construction, and Robert Murray, counsel for Athenex.

2017-07-21

Athenex launches drug trial for Oraxol
Buffalo News
Buffalo drug development company Athenex Inc. is launching an early-stage clinical trial for an oral form of a drug that potentially could be used as part of a treatment for gastric cancer.

Athenex, Inc. address

1001 MAIN STREET
SUITE 600
BUFFALO
14203

Former name

Former name of this company was Kinex Pharmaceuticals LLC, date of change: 2004-08-17.

Former name of this company was Kinex Pharmaceuticals, Inc., date of change: 2013-12-23.

Company jurisdiction

DELAWARE

Entity type

Corporation

Earliest known filing

August 2004

Latest known filing

August 2017

Company filings

SEC filings are a great source of information for companies including investments, company events, and all sorts of other information.

Athenex, Inc. has 69 filings. View Athenex, Inc. filings.

Quarterly Reports

Latest company events

Investment Rounds

Athenex, Inc. recieved 10 investments.

People

We have found 48 people related to Athenex, Inc..